GM-CSF is a proinflammatory cytokine, upregulated in various neurological disorders, such as Alzheimer’s disease, vascular dementia, and multiple sclerosis [79–81]. This evidence concerns the gene CSF2 and early-onset autosomal dominant Alzheimer disease.